Trans Intech LLC - CA San Diego, San Diego 92130

Trans Intech LLC entered the industry of Commercial Medical Research in 1994 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 541712, which describes it as a Commercial Medical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Medical Research. The business provides service to the B2B market.

To acquire more information, please contact Ommid Asbaghi by calling (858) 531-5668 during business hours. You can also write to the business’ Single Location at 11596 Parkhurst Square, San Diego, California CA 92130. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Trans Intech LLC
Representative: Ommid Asbaghi
Place of Business: 11596 Parkhurst Square, San Diego, CA 92130
Contact Number: (858) 531-5668
Type of Service: Commercial Medical Research
SIC Number: 8731
NAICS Number: 541712
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 1994
Income/Year: $100.000 to $499.999
Laborers: 1 to 4
Share This Company:

Trans Intech LLC is a company operating from San Diego, California providing professional Commercial Medical Research and relevant B2B variables. It was founded in 1994 and registered with the SIC code 8731 as Commercial Medical Research, and with the NAICS code 541712 as Commercial Medical Research.

With a current employee count of 1 to 4, Trans Intech LLC has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Ommid Asbaghi at (858) 531-5668 for related queries, or to locate its Single Location using the coordinates 32.929507,-117.22597.

The Single Location can also be found at the street address 11596 Parkhurst Square in San Diego, California 92130 and can be engaged online through the company website at , the company Twitter , and Facebook page .